Regulations.gov document
Requests for Reconsideration at the Division Level Under the Generic Drug User Fee Act…
Notice · FDA-2017-D-5868 · posted Oct 12, 2017
Key facts
| Document ID | FDA-2017-D-5868-0001 |
|---|---|
| Title | Requests for Reconsideration at the Division Level Under the Generic Drug User Fee Act; Draft Guidance for Industry; Availability |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2017-D-5868 |
| Posted | Oct 12, 2017 |
| Federal Register citation | 82 FR 47531 |
| FR document number | 2017-22049 |
| Comment period opens | Oct 12, 2017 |
| Comments due | Dec 12, 2017 |
| Effective date | Oct 12, 2017 |
At a glance
- 1–9 Pages
- No Open for comment
- 1–9 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: